Aaron Schuchart

Insider Reports History

Entity
Individual
Location
C/O Aeglea Biotherapeutics, Inc., 901 S.Mopac Expwy,Bartonoaksplazone,#250, Austin, TX
Signature
/s/ Ryan Trytten, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Aaron Schuchart:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LUMOS PHARMA, INC. Chief Business Officer Common Stock 6.68K $19K $2.84 Apr 1, 2024 Direct
LUMOS PHARMA, INC. Chief Business Officer Stock Option (Right to Buy) 12K Apr 1, 2024 Direct

Insider Reports Filed by Aaron Schuchart

Symbol Company Period Transactions Value $ Form Type Date Filed Role
(LUMO) LUMOS PHARMA, INC. Apr 1, 2024 2 $2.84K 4 Apr 3, 2024 Chief Business Officer
(LUMO) LUMOS PHARMA, INC. Feb 1, 2024 1 -$608 4 Feb 5, 2024 Chief Business Officer
LUMO LUMOS PHARMA, INC. Feb 1, 2023 3 $3.15K 4 Feb 3, 2023 Chief Business Officer
LUMO LUMOS PHARMA, INC. Feb 1, 2022 3 $9.5K 4 Feb 3, 2022 Chief Business Officer
LUMO LUMOS PHARMA, INC. Aug 11, 2021 2 $14.8K 4 Aug 13, 2021 Chief Business Officer
LUMO LUMOS PHARMA, INC. Jun 1, 2021 1 $0 4 Jun 3, 2021 Chief Business Officer
LUMO LUMOS PHARMA, INC. May 19, 2021 0 $0 3 May 28, 2021 Chief Business Officer